Development of targeted therapeutic agents for the treatment of FXTAS (2 of 6)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/30/07 → 6/30/12

Funding

  • National Institutes of Health: $792,986.00
  • National Institutes of Health: $793,447.00
  • National Institutes of Health: $860,314.00
  • National Institutes of Health: $74,991.00
  • National Institutes of Health: $787,990.00
  • National Institutes of Health: $798,611.00
View all
View less

ASJC

  • Medicine(all)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.